Cargando…

Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study

BACKGROUND: Congenital adrenal hyperplasia (CAH) cause life-threatening adrenal crisis. It also affects fetal sex development and can result in incorrect sex assignment at birth. In 1989, a newborn screening program for congenital adrenal hyperplasia (CAH) was introduced in Tokyo. Here we present th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuji, Atsumi, Konishi, Kaoru, Hasegawa, Satomi, Anazawa, Akira, Onishi, Toshikazu, Ono, Makoto, Morio, Tomohiro, Kitagawa, Teruo, Kashimada, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681082/
https://www.ncbi.nlm.nih.gov/pubmed/26671474
http://dx.doi.org/10.1186/s12887-015-0529-y
_version_ 1782405696572096512
author Tsuji, Atsumi
Konishi, Kaoru
Hasegawa, Satomi
Anazawa, Akira
Onishi, Toshikazu
Ono, Makoto
Morio, Tomohiro
Kitagawa, Teruo
Kashimada, Kenichi
author_facet Tsuji, Atsumi
Konishi, Kaoru
Hasegawa, Satomi
Anazawa, Akira
Onishi, Toshikazu
Ono, Makoto
Morio, Tomohiro
Kitagawa, Teruo
Kashimada, Kenichi
author_sort Tsuji, Atsumi
collection PubMed
description BACKGROUND: Congenital adrenal hyperplasia (CAH) cause life-threatening adrenal crisis. It also affects fetal sex development and can result in incorrect sex assignment at birth. In 1989, a newborn screening program for congenital adrenal hyperplasia (CAH) was introduced in Tokyo. Here we present the results of this screening program in order to clarify the efficiency of CAH screening and the incidence of CAH in Japan. METHOD: From 1989 to 2013, a total of 2,105,108 infants were screened for CAH. The cutoff level for diagnosis of CAH was adjusted for gestational age and birth weight. RESULTS: A total of 410 infants were judged positive, and of these, 106 patients were diagnosed with CAH, indicating a positive predictive value (PPV) of 25.8 %. Of the 106 patients, 94 (88.7 %) were diagnosed with 21-OHD. Of these 94 patients, 73 were diagnosed with the salt wasting form, 14 with the simple virilising form and 7 with the nonclassical form (NC21OHD). The mean birth weight and gestational age were 3192 ± 385 g and 38.9 ± 1.38 weeks. 11 out of 44 female patients were assigned as female according to their screening result. CONCLUSIONS: These data suggest that the newborn screening in Tokyo was effective, especially for sex assignment and preventing fatal adrenal crisis. The incidence of CAH was similar to that measured in previous Japanese screening studies, and it was also similar to that of western countries. The incidence of NC21OHD in Japan in the present study was lower than that in western countries as previous studies reported. The screening program achieved higher PPV than previous CAH screening studies, which might be due to the use of variable cutoffs according to gestational age and birth weight. However, most of the neonates born at 37 weeks or less that were referred to hospital were false-positives. Further changes are needed to reduce the number of false positive preterm neonates.
format Online
Article
Text
id pubmed-4681082
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46810822015-12-17 Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study Tsuji, Atsumi Konishi, Kaoru Hasegawa, Satomi Anazawa, Akira Onishi, Toshikazu Ono, Makoto Morio, Tomohiro Kitagawa, Teruo Kashimada, Kenichi BMC Pediatr Research Article BACKGROUND: Congenital adrenal hyperplasia (CAH) cause life-threatening adrenal crisis. It also affects fetal sex development and can result in incorrect sex assignment at birth. In 1989, a newborn screening program for congenital adrenal hyperplasia (CAH) was introduced in Tokyo. Here we present the results of this screening program in order to clarify the efficiency of CAH screening and the incidence of CAH in Japan. METHOD: From 1989 to 2013, a total of 2,105,108 infants were screened for CAH. The cutoff level for diagnosis of CAH was adjusted for gestational age and birth weight. RESULTS: A total of 410 infants were judged positive, and of these, 106 patients were diagnosed with CAH, indicating a positive predictive value (PPV) of 25.8 %. Of the 106 patients, 94 (88.7 %) were diagnosed with 21-OHD. Of these 94 patients, 73 were diagnosed with the salt wasting form, 14 with the simple virilising form and 7 with the nonclassical form (NC21OHD). The mean birth weight and gestational age were 3192 ± 385 g and 38.9 ± 1.38 weeks. 11 out of 44 female patients were assigned as female according to their screening result. CONCLUSIONS: These data suggest that the newborn screening in Tokyo was effective, especially for sex assignment and preventing fatal adrenal crisis. The incidence of CAH was similar to that measured in previous Japanese screening studies, and it was also similar to that of western countries. The incidence of NC21OHD in Japan in the present study was lower than that in western countries as previous studies reported. The screening program achieved higher PPV than previous CAH screening studies, which might be due to the use of variable cutoffs according to gestational age and birth weight. However, most of the neonates born at 37 weeks or less that were referred to hospital were false-positives. Further changes are needed to reduce the number of false positive preterm neonates. BioMed Central 2015-12-15 /pmc/articles/PMC4681082/ /pubmed/26671474 http://dx.doi.org/10.1186/s12887-015-0529-y Text en © Tsuji et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tsuji, Atsumi
Konishi, Kaoru
Hasegawa, Satomi
Anazawa, Akira
Onishi, Toshikazu
Ono, Makoto
Morio, Tomohiro
Kitagawa, Teruo
Kashimada, Kenichi
Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study
title Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study
title_full Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study
title_fullStr Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study
title_full_unstemmed Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study
title_short Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study
title_sort newborn screening for congenital adrenal hyperplasia in tokyo, japan from 1989 to 2013: a retrospective population-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681082/
https://www.ncbi.nlm.nih.gov/pubmed/26671474
http://dx.doi.org/10.1186/s12887-015-0529-y
work_keys_str_mv AT tsujiatsumi newbornscreeningforcongenitaladrenalhyperplasiaintokyojapanfrom1989to2013aretrospectivepopulationbasedstudy
AT konishikaoru newbornscreeningforcongenitaladrenalhyperplasiaintokyojapanfrom1989to2013aretrospectivepopulationbasedstudy
AT hasegawasatomi newbornscreeningforcongenitaladrenalhyperplasiaintokyojapanfrom1989to2013aretrospectivepopulationbasedstudy
AT anazawaakira newbornscreeningforcongenitaladrenalhyperplasiaintokyojapanfrom1989to2013aretrospectivepopulationbasedstudy
AT onishitoshikazu newbornscreeningforcongenitaladrenalhyperplasiaintokyojapanfrom1989to2013aretrospectivepopulationbasedstudy
AT onomakoto newbornscreeningforcongenitaladrenalhyperplasiaintokyojapanfrom1989to2013aretrospectivepopulationbasedstudy
AT moriotomohiro newbornscreeningforcongenitaladrenalhyperplasiaintokyojapanfrom1989to2013aretrospectivepopulationbasedstudy
AT kitagawateruo newbornscreeningforcongenitaladrenalhyperplasiaintokyojapanfrom1989to2013aretrospectivepopulationbasedstudy
AT kashimadakenichi newbornscreeningforcongenitaladrenalhyperplasiaintokyojapanfrom1989to2013aretrospectivepopulationbasedstudy